Thromb Haemost 1964; 11(02): 317-326
DOI: 10.1055/s-0038-1654832
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Investigation on Adenosine Diphosphate (ADP) Induced Platelet Adhesiveness in Vitro Part III. The Inactivation of ADP in Plasma

A. E Ödegaard
1   Institute for Thrombosis Research. Head: Professor H. Stormorken, M. D. and Medical Department A*. Head: Professor P. A. Owren, M. DUniversity Hospital, Pikshospitalet, Oslo, Norway
,
B. A Skälhegg
1   Institute for Thrombosis Research. Head: Professor H. Stormorken, M. D. and Medical Department A*. Head: Professor P. A. Owren, M. DUniversity Hospital, Pikshospitalet, Oslo, Norway
,
A. J Hellem*)
1   Institute for Thrombosis Research. Head: Professor H. Stormorken, M. D. and Medical Department A*. Head: Professor P. A. Owren, M. DUniversity Hospital, Pikshospitalet, Oslo, Norway
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Summary

The results of investigations on the ADP inactivating system in platelet poor plasma are given. The activity of the system is maximal at about 37° C. and is irreversibly destroyed by heating for 15 minutes at 58° C. The system is non dialysable and is inactivated by KCN, cysteine, 2.3-dimercaptopropanole (BAL) and penicillamine at concentrations between 2 · 10∼3 and 5 · 103M.

The ADP inactivating ability of platelet poor plasma from normals, patients with thyrotoxicosis, diabetes mellitus, hypercholesterolemia and some patients with bleeding disorders has been estimated. The inactivation by plasma from patients with thyrotoxicosis is markedly increased as compared with the other groups. A possible relationship between the low frequency of thromboembolism and the increased ADP degradation in these patients is discussed.

*) Granted by the Norwegian Council on Cardiovascular Diseases.


 
  • References

  • Barden H, Lazarus S. S. Histochemical characteristics of adenosine triphosphate dephosphorylating enzymes in rabbit pancreas. J. Histochem. Cytochem. 11: 578 1963;
  • Born GVR, Gross M. J. The aggregation of blood platelets. J. Physiol. (Lond) 168: 178 1962;
  • Egeberg O. The influence of thyroid function on the blood clotting system. Scand. J. clin. Lab. Invest. 15: 1 1963;
  • Hellem A. J. Demonstration of a substance in the red cells affecting the adhesiveness of blood platelets. Proc. VII Congr. int. Soc. Hemat., Rome. 1958
  • Hellem A. J. The adhesiveness of human blood platelets in vitro. Thesis. Scand. J. clin. Lab. Invest.. 12. suppl. 51 1960
  • Hellem A. J, Ödegaard A. E, Skälhegg B. A. Investigations on adenosine diphosphate (ADP) induced platelet adhesiveness in vitro. Part. 1. The ADP-platelet reaction in various experimental conditions. Thrombos. Diathes. haemorrh. (Stuttg) 10: 61 1963;
  • Jörgensen S. Breakdown of adenine and hypoxanthine nucleotides and nucleosides in human plasma. Acta pharmocol. (Kbh) 12: 294 1956;
  • Novikoff A. B, Goldfischer S. Nucleosidediphosphatase activity in the Golgi apparatus and its usefulness for cytological studies. Proc. nat. Acad. Sci. (Wash) 47: 802 1961;
  • O’Brien J. R. The adhesiveness of native platelets and its prevention. J. clin. Path. 14: 140 1961;
  • O’Brien J. R. Platelet aggregation. Part I. Some effects of the adenosine phosphates, thrombin and cocaine upon platelet adhesiveness. J. clin. Path. 15: 446 1962;
  • Ödegaard A. E, Skälhegg B. A, Hellem A. J. Increased activity of “Anti-Willebrand Factor” in diabetic plasma. Thrombos. Diathes. haemorrh. (Stuttg) 11: 27 1964;
  • Öllgaard E. Macroscopic studies of platelet aggregation. Nature of an aggregating factor in red blood cells and platelets. Thrombos. Diathes. heamorrh. (Stuttg) 06: 86 1961;